We are writing to provide an important recommendation for laboratories transitioning to the Abbott Anti-HCV NEXT assay.

If you are planning to move, or have recently moved, to the Abbott Anti-HCV NEXT assay, we strongly recommend updating your quality control materials accordingly:

Recommended control: Optitrol Yellow
Previous control (for prior assay): Optitrol Blue
This recommendation ensures your QC program remains optimally matched to the performance characteristics of the Abbott Anti-HCV NEXT assay.

If you have any questions about this transition or would like further guidance, please don't hesitate to contact the NRL team below or at qconnect@nrlquality.org.au

Early bird registrations for the 2026 NRL Workshop are closing soon!

Join leading scientists and global experts driving progress in infectious disease testing, powered by innovation, collaboration, and real-world impact.

🔬 Three days of learning, networking, and cutting-edge insights
💡 Hear from the field’s most influential voices
📍 Connect with peers and gain practical, hands-on knowledge
💸 Don’t miss out - come join us.

2025 EDCNet MU report subscriptions are now inactive, so if you haven't already it's a great time to set yourself up for a stress-free MU reporting time and re-subscribe for 2026.
If you haven't utilized this time saving function yet - hit the link and get yourself sorted for this year!!